We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Qiagen and CytoPathfinder Combines Technologies in RNAi Screening

News   May 24, 2006

 
Qiagen and CytoPathfinder Combines Technologies in RNAi Screening
 
 
 

RELATED ARTICLES

Combining CRISPR With Drug Discovery to Understand Treatment Efficacy

News

Researchers combine CRISPR gene-editing technology with drug discovery to understand why treatment works (or doesn’t).

READ MORE

Promising Molecules for Stabilizing Abnormal Proteins That Cause AL Amyloidosis

News

Scientists at Scripps Research have identified a group of small molecules that prevent structural changes to proteins that are at the root of AL amyloidosis, a progressive and often fatal disease.

READ MORE

Kelp Is at Hand: A Treasure Trove of New Drugs Underwater

News

A new study reveals for the first time that a common species of seaweed, Laminaria ochroleuca, is a rich source of bacteria with antimicrobial and anticancer activities, and potential new drug candidates.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE